Advisornet Financial’s Fulgent Genetics FLGT Stock Holding History

Advisornet Financial’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$492	Hold	24	–	–	﹤0.01%	2099
2026 Q1	$382	Hold	24	–	–	﹤0.01%	2121
2025 Q4	$630	Hold	24	–	–	﹤0.01%	2064
2025 Q3	$542	Hold	24	–	–	﹤0.01%	2062
2025 Q2	$477	Hold	24	–	–	﹤0.01%	2064
2025 Q1	$406	Sell	24 -12	-33%	-$204	﹤0.01%	1997
2024 Q4	$665	Sell	36 -149	-81%	-$2.91K	﹤0.01%	1726
2024 Q3	$4.02K	Buy	185 +149	+414%	+$3.33K	﹤0.01%	1623
2024 Q2	$706	Hold	36	–	–	﹤0.01%	1882
2024 Q1	$781	Hold	36	–	–	﹤0.01%	1825
2023 Q4	$1.04K	Hold	36	–	–	﹤0.01%	1875
2023 Q3	$963	Hold	36	–	–	﹤0.01%	1806
2023 Q2	$1.33K	Hold	36	–	–	﹤0.01%	1803
2023 Q1	$1.12K	Hold	36	–	–	﹤0.01%	1848
2022 Q4	$1.07K	Hold	36	–	–	﹤0.01%	1814
2022 Q3	$1K	Sell	36 -55	-60%	-$2.76K	﹤0.01%	1761
2022 Q2	$5K	Buy	91 +55	+153%	+$3.02K	﹤0.01%	1504
2022 Q1	$2K	Buy	36 +24	+200%	+$1.58K	﹤0.01%	1778
2021 Q4	$1K	Buy	+12	New	+$1.05K	﹤0.01%	1918

Other funds holding FLGT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Advisornet Financial's FLGT Position: Q2 2026 in Review

Advisornet Financial held its Fulgent Genetics (FLGT) position steady in Q2 2026 at 24 shares worth $492. The position accounts for ﹤0.01% of the portfolio, ranked #2099.

Advisornet Financial first reported a position in FLGT in Q4 2021 and has held it in 19 quarters since. The position peaked at $5K in Q2 2022. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

Advisornet Financial held 24 shares of Fulgent Genetics worth $492 as of Q2 2026.
Advisornet Financial left its Fulgent Genetics share count unchanged in Q2 2026.
Fulgent Genetics made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #2099 holding.
Advisornet Financial first reported a position in Fulgent Genetics in Q4 2021 and has held it in 19 quarters since.
Advisornet Financial's Fulgent Genetics position peaked at $5K in Q2 2022.
142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.